Jamkas Pharmaceuticals Private Limited

Jamkas Pharmaceuticals Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
CIN U24239HR2021PTC096279 Incorporated 13 July 2021 ROC Haryana HQ Panchkula, Haryana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹6 Cr
Issued & subscribed
Open charges
₹30 Cr
Satisfied ₹25 Cr
Company age
5 yrs
Est. 2021
Directors on board
7
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting

About Jamkas Pharmaceuticals Private Limited

Data last updated:

Jamkas Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 13 July 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24239HR2021PTC096279. Its GSTIN is 01AAFCJ2520G1Z9 (Jammu and Kashmir).

The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹6 Cr. It is led by directors including Vaneet Jain and Rupali Singla.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No.590 Sector 4 Urban Estate, Panchkula, Haryana, India – 134112.

As per MCA filings, the company has open charges of ₹30 Cr and satisfied charges of ₹25 Cr on record.

Jamkas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-09-0008578).

Company details

CIN U24239HR2021PTC096279
Registration Number 096279
Incorporation Date 13 July 2021
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-JK-09-0008578
Key People
Vaneet Jain Director Rupali Singla Director Rakesh Kumar Director

Recognitions & Rankings of Jamkas Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-JK-09-0008578

Contact details

Jamkas Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    House No.590 Sector 4 Urban Estate, Panchkula, Haryana, India – 134112
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Jamkas Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Jamkas Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Jamkas Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Financials of Jamkas Pharmaceuticals Private Limited

FY 2025 filings available

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Jamkas Pharmaceuticals Private Limited, buy the company report.

Board of directors of Jamkas Pharmaceuticals Private Limited

Jamkas Pharmaceuticals has 7 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Vaneet Jain
Also directs: Ethics Health-Care Private Limited, Novolilly Pharmaceutical Private Limited, Vanbio Lifesciences Limited and 2 more
Director13 Jul 20215 Years 3 MonthsCurrent
Rupali Singla
Also directs: Vanbio Lifesciences Limited, Novotropics Healthcare Limited
Director13 Jul 20215 Years 3 MonthsCurrent
Rakesh KumarDirector15 Mar 20242 Years 7 MonthsCurrent
Sayam MittalDirector08 Jan 20242 Years 10 MonthsCurrent
Manish GoyalDirector04 Jan 20251 Years 10 MonthsCurrent
Kanav GoyalAdditional Director22 Dec 20250 Years 10 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Auditor

Jamkas Pharmaceuticals Private Limited is audited by MOHIT G & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
MOHIT G & ASSOCIATESFY 2024035809N

Shareholding

The shareholding of Jamkas Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Jamkas Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹30 Cr
Satisfied charges
₹25 Cr
Breakdown by lending institutions
Sidbi₹30.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Mar 2026101339402Sidbi₹30 CrOpen
12 Apr 2024100919023Hdfc Bank Limited₹25 CrSatisfied

To see the full charge records of Jamkas Pharmaceuticals Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Jamkas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Jamkas Pharmaceuticals Private Limited has 1 active EPFO establishment as of Nov 29, 2024.

Active EPFO establishments
1

GST

Jamkas Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
01AAFCJ2520G1Z9Jammu and KashmirActive02 Dec 2022

To see the full GST registrations and return filing status of Jamkas Pharmaceuticals Private Limited, buy the company report.

Recent activity

Jamkas Pharmaceuticals Private Limited has 7 board changes on record since 2021: 7 appointments. The latest: Gurjinder Singh was appointed as Director on 01 Jul 2026.

Appointed
Gurjinder Singh was appointed as Director.
Charges
A charge registered on 12 Apr 2024 via Charge ID 100919023 with Hdfc Bank Limited was fully satisfied on 01 Jun 2026.
Charges
A charge with Sidbi amounted to Rs. 30.00 Cr with Charge ID 101339402 was registered on 26 Mar 2026.
Appointed
Kanav Goyal was appointed as Additional Director.
AGM
Jamkas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jamkas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Appointed
Manish Goyal was appointed as Director.
Charges
A charge with Hdfc Bank Limited of Rs. 25.00 Cr registered on 12 Apr 2024 with Charge ID 100919023 was modified on 18 Dec 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Cr with Charge ID 100919023 was registered on 12 Apr 2024.
Appointed
Rakesh Kumar was appointed as Director.
Appointed
Sayam Mittal was appointed as Director.
Appointed
Rupali Singla was appointed as Director.

2 earlier events are in the company report.

Frequently asked questions

Jamkas Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 13 July 2021 (5+ years old) and is registered under CIN U24239HR2021PTC096279.

Jamkas Pharmaceuticals has 7 current directors:

The latest financial statements of Jamkas Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Jamkas Pharmaceuticals is 01AAFCJ2520G1Z9, registered in Jammu and Kashmir.

The CIN (Corporate Identification Number) of Jamkas Pharmaceuticals is U24239HR2021PTC096279. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Jamkas Pharmaceuticals was incorporated on 13 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Haryana.

Gurjinder Singh was appointed as Director on 01 Jul 2026. Kanav Goyal was appointed as Additional Director on 22 Dec 2025. Manish Goyal was appointed as Director on 04 Jan 2025. Jamkas Pharmaceuticals has 7 board changes on record in total.

Yes, Jamkas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JK-09-0008578).

The registered office of Jamkas Pharmaceuticals is at House No.590 Sector 4 Urban Estate, Panchkula, Haryana, India – 134112.

Jamkas Pharmaceuticals operates in the pharma industry, in the api manufacturers segment.